Four years ago today, I was diagnosed with primary mediastinal B-cell lymphoma, a form of diffuse large B-cell lymphoma, a form of non-Hodgkin's lymphoma.
Three years ago on May 26, I was declared in complete remission at MD Anderson, a month after a CAR T-cell infusion. I am still in complete remission after multiple PET scans and CT scans.
The specific therapy I received (Yescarta) was approved by the FDA for refractory diffuse large B-cell lymphoma on October 2017. It was the second such therapy approved by the FDA, and the second that year, after Kymriah in August.
Feels a bit odd to be saved by a class of therapy more than three decades younger than I am.
Three years ago on May 26, I was declared in complete remission at MD Anderson, a month after a CAR T-cell infusion. I am still in complete remission after multiple PET scans and CT scans.
The specific therapy I received (Yescarta) was approved by the FDA for refractory diffuse large B-cell lymphoma on October 2017. It was the second such therapy approved by the FDA, and the second that year, after Kymriah in August.
Feels a bit odd to be saved by a class of therapy more than three decades younger than I am.
https://en.wikipedia.org/wiki/Axicabtagene_ciloleucel
https://en.wikipedia.org/wiki/CAR_T_cell